证券之星消息，10月10日医疗美容板块较上一交易日下跌0.5%，锦波生物领跌。当日上证指数报收于 3897.03，下跌0.94%。深证成指报收于13355.42，下跌2.7%。医疗美容板块个股涨跌见下表： | 代码 | | | 名称 | | | | | --- | --- | --- | --- | --- | --- | --- | | 300896 爱美客 | 1905.34万 | 3.90% | -1173.79万 | -2.40% | -731.55万 | -1.50% | | 000615 *ST美谷 | -116.92万 | -5.51% | -150.21万 | -7.08% | 267.12万 | 12.59% | | 688363 华熙生物 | -372.04万 | -1.72% | 792.57万 | 3.66% | -420.53万 | -1.94% | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- ...

《风险提示》首个披露的案例，聚焦近期高发的"农业云养殖"领域。据介绍，某地市民孙女士经朋友介 绍，接触到一款"云养黑猪"投资项目。该平台对外宣称，投资者无需实地参与养殖，认购后即可享受年 化60%的固定收益。孙女士投入资金后，平台以"系统升级"为由冻结提现功能，随后关闭APP。经查， 该项目无真实养殖场，利用层级返利发展4万会员，涉案金额超亿元，涉嫌非法传销活动。 深圳市委金融办特别提示，近年来，"云养经济"领域违法犯罪活动高发。一些不法分子往往打着"发展 农业产业"的幌子，将正常的农产品种养、销售环节包装成"投资融资项目"，借助互联网平台广泛宣传 推广，从事违法犯罪活动，既侵害公众合法利益，也对农业产业健康发展造成负面影响。 据了解，此类欺诈活动存在三大典型特征：一是以"农业+科技"为噱头，炒作田园生活、有机生态、智 慧农业等热点，伪造养殖、种植的视频图片来虚构或夸大实际生产场景，对外宣称低风险、高收益，但 真实经营模式难以支撑其承诺收益；二是网络属性强，不法分子依托互联网、移动应用程序开展运营， 通过网上支付工具收付资金，风险波及范围广、扩散速度快，资金监管和追踪难度大；三是存在多种违 法犯罪风险，不法分 ...

证券之星消息，10月9日医疗美容板块较上一交易日上涨0.18%，华熙生物领涨。当日上证指数报收于 3933.97，上涨1.32%。深证成指报收于13725.56，上涨1.47%。医疗美容板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | | | 名称 │主力净流入（元）│主力净占比│游资净流入（元）│游资净占比│散户净流入（元）│散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 688363 华熙生物 | 546.13万 | 2.45% | 387.25万 | 1.74% | -933.39万 | -4.19% | | 000615 *ST美谷 | -255.12万 | -6.23% | -120.45万 | -2.94% | 375.58万 | 9.17% | | 300896 爱美客 | -4711.15万 | -8.95% | -3519.40万 | -6.69% | 8230.55万 | 15.63% | | 代码 | 名称 ...

新华社音视频部制作 记者：高菲菲 王伟 秋季出行应该做好哪些皮肤护理攻略？新华社《健康我来说》邀请北京大学第一医院整形烧伤科主任温 冰，为大家答疑解惑。 ...

9月27日，由商务部国际商务官员研修学院组织的发展中国家女性企业家代表团走进杭州媛颂集团，开展"发展中国家女性企业家电子商务和数字经济能力提 升研修班"实地教学活动。来自"一带一路"沿线国家的女性企业家代表通过实地考察和深度交流，共同探讨颜值经济高质量发展路径。 作为浙江省颜值经济产业标杆企业，媛颂集团向国际代表团展示了中国美丽健康产业的创新成果与发展经验。集团执行总裁马伟伟介绍，媛颂成立于2015 年，现已发展成为集医疗美容、生物科技、生命科学及文化教育于一体的综合性健康产业集团，在全国拥有30家直营机构和超7000名员工。 数据显示，中国颜值经济市场规模已突破3000亿元，年均增速超16%，持续领跑全球市场。预计未来五年，轻医美赛道规模将冲刺5000亿元，展现出巨大的 市场潜力。 代表团一行参观了媛颂数字美学设计中心、透明产品展示厅及客户体验中心，亲身体验了面部美学分析等数字化技术应用。马伟伟详细介绍了集团打造的全 球化医疗人才网络，以及涵盖8大环节的"媛颂严选"产品准入机制，展现了企业对品质的严格把控。 在专题座谈环节，双方就美丽健康产业发展历程、监管体系与创新模式等进行深入交流。媛颂集团不仅与艾伯维、 ...

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

证券之星消息，9月30日医疗美容板块较上一交易日上涨0.15%，*ST美谷领涨。当日上证指数报收于 3882.78，上涨0.52%。深证成指报收于13526.51，上涨0.35%。医疗美容板块个股涨跌见下表： | 代码 | | | 名称 | | | | | --- | --- | --- | --- | --- | --- | --- | | 688363 华熙生物 | 1243.52万 | 7.57% | -958.56万 | -5.83% | -284.96万 | -1.73% | | 000615 *ST美谷 | -124.73万 | -3.03% | 85.72万 | 2.08% | 39.01万 | 0.95% | | 300896 爱美客 | -3429.32万 | -7.89% | 79.20万 | 0.18% | 3350.13万 | 7.71% | 从资金流向上来看，当日医疗美容板块主力资金净流出2310.53万元，游资资金净流出793.65万元，散户 资金净流入3104.18万元。医疗美容板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345 ...

Summary of Key Points Core Viewpoint - Langzi Co., Ltd. has disclosed its total guarantee amount and financial performance, indicating significant leverage and revenue composition across its business segments [1]. Financial Guarantees - The total guarantee amount for the company and its subsidiaries is 1.906 billion yuan, with an external guarantee balance of approximately 1.129 billion yuan, representing 40.51% of the company's audited net assets for 2024 [1]. - The company has provided guarantees totaling 36 million yuan to entities outside the consolidated financial statements, accounting for 12.92% of the audited net assets for 2024 [1]. - The company has a guarantee balance of 10 million yuan for its subsidiary, Beijing Rhine Clothing Co., Ltd., which has a debt-to-asset ratio exceeding 70% [1]. Revenue Composition - For the first half of 2025, the revenue composition of Langzi Co., Ltd. is as follows: - Medical beauty accounts for 47.81% - Fashion women's wear accounts for 35.44% - Green baby products account for 15.6% - Other businesses account for 1.16% [1]. Market Capitalization - As of the report date, Langzi Co., Ltd. has a market capitalization of 7.6 billion yuan [1].

证券之星消息，9月29日医疗美容板块较上一交易日上涨0.36%，华熙生物领涨。当日上证指数报收于 3862.53，上涨0.9%。深证成指报收于13479.43，上涨2.05%。医疗美容板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 688363 | 华熙生物 | 55.02 | 0.86% | 2.61万 | 1.42亿 | | 000615 | *ST美谷 | 3.28 | 0.61% | 12.38万 | 4002.69万 | | 300896 | 爱美客 | 182.20 | -0.01% | 2.67万 | 4.81亿 | | 832982 | 锦波生物 | 284.30 | -0.65% | 4900.44 | 1.40亿 | | 代码 | | | 名称 主力净流入（元） 主力净占比 游资净流入（元） 游资净占比 散户净流入（元） 散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 688363 ...

从资金流向上来看，当日医疗美容板块主力资金净流出2358.82万元，游资资金净流入5878.3万元，散户 资金净流出3519.48万元。医疗美容板块个股资金流向见下表： 证券之星消息，9月26日医疗美容板块较上一交易日下跌0.06%，锦波生物领跌。当日上证指数报收于 3828.11，下跌0.65%。深证成指报收于13209.0，下跌1.76%。医疗美容板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300896 | 爱美客 | 182.21 | 1.31% | 2.97万 | 5.40 Z | | 000615 | *ST美谷 | 3.26 | -0.61% | 21.34万 | 7084.52万 | | 688363 | 华熙生物 | 54.55 | -1.00% | 2.85万 | 1.57亿 | | 832982 | 锦波生物 | 286.15 | -1.43% | 7010.12 | 2.00亿 | | 代码 | | | 名称 | | | | | --- | --- ...